Skip to main content

Table 3 Swedish universities Scales of Personality (SSP) raw scores (mean [standard deviation]) and 95% confidence interval (CI) of the difference between baseline and follow-up in patients with psychotic illness and non-psychotic controls

From: Stability of personality traits over a five-year period in Swedish patients with schizophrenia spectrum disorder and non-psychotic individuals: a study using the Swedish universities scales of personality

    Somatic Trait Anxiety Psychic Trait Anxiety Stress Susceptibility
   N Baseline Follow-up CI Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 36 39.4 (7.7) 44.4 (7.8) −0.25 – 0.15 2.08 (0.48) 2.13 (0.53) −0.09 – 0.27 2.45 (0.62) 2.36 (0.61) −0.19 – 0.16
  Control 76 41.1 (7.8) 47.5 (7.8) −0.06 – 0.12 1.58 (0.46) 1.55 (0.45) 0.11–0.26 1.66 (0.50) 1.48 (0.39) −0.05 – 0.14
ALL Men 75 40.7 (7.9) 46.5 (8.0) −0.14 – 0.08 1.68 (0.48) 1.71 (0.56) 0.04–0.22 1.92 (0.68) 1.79 (0.66) −0.06 – 0.14
  Women 37 40.1 (7.7) 46.4 (7.9) −0.08 – 0.21 1.74 (0.52) 1.78 (0.53) 0.07–0.34 1.90 (0.60) 1.70 (0.55) −0.17 – 0.16
PATIENT Men 28 39.9 (7.5) 44.9 (7.6) −0.39 – 0.09 2.05 (0.39) 2.19 (0.51) −0.17 – 0.24 2.47 (0.60) 2.43 (0.52) −0.24 – 0.17
  Women 8 37.5 (8.2) 42.6 (8.2) 0.02–0.55 2.21 (0.71) 1.93 (0.57) −0.17 – 0.74 2.38 (0.71) 2.09 (0.84) −0.40 – 0.51
CONTROL Men 47 41.2 (8.1) 47.5 (8.0) −0.06 – 0.14 1.47 (0.39) 1.43 (0.36) 0.10–0.28 1.60 (0.49) 1.41 (0.37) −0.02 – 0.20
  Women 29 40.8 (7.4) 47.5 (7.5) −0.16 – 0.18 1.75 (0.71) 1.74 (0.52) 0.04–0.33 1.77 (0.51) 1.59 (0.40) −0.21 – 0.17
   Lack of Assertiveness Impulsiveness Adventure Seeking
   Baseline Follow-up CI Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 2.46 (0.55) 2.47 (0.53) −0.13 – 0.28 2.33 (0.52) 2.25 (0.51) −0.07 – 0.23 2.50 (0.58) 2.38 (0.61) 10.04–0.29
  Control 1.87 (0.47) 1.82 (0.44) −0.04 – 0.11 2.30 (0.46) 2.19 (0.47) 0.02–0.20 2.53 (0.52) 2.39 (0.51) 0.07–0.22
ALL Men 2.06 (0.61) 2.02 (0.58) −0.06 – 0.16 2.23 (0.47) 2.15 (0.47) −0.01 – 0.17 2.57 (0.58) 2.42 (0.56) 0.06–0.25
  Women 2.04 (0.46) 2.05 (0.53) −0.07 – 0.15 2.48 (0.45) 2.34 (0.49) 0.01–0.28 2.42 (0.43) 2.33 (0.50) −0.01 – 0.21
PATIENT Men 2.48 (0.60) 2.52 (0.46) −0.18 – 0.33 2.28 (0.51) 2.21 (0.52) −0.12 – 0.24 2.52 (0.62) 2.34 (0.65) −0.02 – 0.38
  Women 2.36 (0.38) 2.30 (0.76) −0.21 – 0.35 2.52 (0.51) 2.38 (0.48) −0.22 – 0.49 2.46 (0.39) 2.54 (0.46) −0.33 – 0.19
CONTROL Men 1.81 (0.47) 1.72 (0.41) −0.06 – 0.13 2.19 (0.44) 2.11 (0.44) −0.02 – 0.20 2.61 (0.55) 2.47 (0.51) 0.04–0.24
  Women 1.96 (0.45) 1.98 (0.44) −0.09 – 0.16 2.47 (0.44) 2.33 (0.50) −0.00 – 0.30 2.41 (0.44) 2.27 (0.50) 0.02–0.27
   Detachment Social Desirability Embitterment
   Baseline Follow-up CI Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 2.77 (0.53) 2.83 (0.45) −0.14 – 0.17 2.77 (0.53) 2.83 (0.45) −0.24 – 0.13 2.23 (0.50) 2.22 (0.55) −0.15 – 0.17
  Control 2.83 (0.37) 2.92 (0.35) −0.02 – 0.12 2.83 (0.37) 2.92 (0.35) −0.15 - -0.03 1.60 (0.41) 1.47 (0.40) 0.05–0.20
ALL Men 2.80 (0.43) 2.88 (0.39) −0.05 – 0.12 2.80 (0.43) 2.88 (0.39) −0.16 – 0.00 1.82 (0.52) 1.72 (0.59) 0.01–0.20
  Women 2.82 (0.42) 2.90 (0.38) −0.09 – 0.18 2.82 (0.42) 2.90 (0.38) −0.21 – 0.06 1.75 (0.56) 1.69 (0.59) −0.06 – 0.18
PATIENT Men 2.82 (0.56) 2.80 (0.46) −0.14 – 0.20 2.82 (0.56) 2.80 (0.46) −0.18 – 0.21 2.23 (0.44) 2.23 (0.57) −0.20 – 0.20
  Women 2.61 (0.42) 2.91 (0.44) −0.51 – 0.48 2.61 (0.42) 2.91 (0.44) −0.87 – 0.26 2.23 (0.69) 2.17 (0.51) −0.22 – 0.34
CONTROL Men 2.79 (0.34) 2.93 (0.34) −0.05 – 0.13 2.79 (0.34) 2.93 (0.34) −0.21 - − 0.07 1.58 (0.39) 1.42 (0.34) 0.08–0.25
  Women 2.88 (0.41) 2.90 (0.36) -0.07 – 0.20 2.88 (0.41) 2.90 (0.36) −0.12 – 0.09 1.62 (0.45) 1.56 (0.47) −0.08 – 0.20
   Trait Irritability Mistrust   
   Baseline Follow-up CI Baseline Follow-up CI   
ALL Patient 2.35 (0.57) 2.13 (0.57) 0.03–0.40 2.26 (0.58) 2.26 (0.52) −0.13 – 0.15   
  Control 2.21 (0.48) 2.03 (0.49) 0.09–0.26 1.75 (0.50) 1.60 (0.47) 0.06–0.24   
ALL Men 2.26 (0.49) 2.04 (0.53) 0.12–0.31 1.97 (0.56) 1.86 (0.57) 0.02–0.21   
  Women 2.24 (0.55) 2.11 (0.50) −0.03 – 0.29 1.81 (0.59) 1.72 (0.58) −0.03 – 0.21   
PATIENT Men 2.36 (0.56) 2.16 (0.53) 0.01–0.38 2.28 (0.58) 2.25 (0.53) −0.14 – 0.21   
  Women 2.32 (0.66) 2.04 (0.74) −0.37 – 0.94 2.20 (0.62) 2.29 (0.55) −0.24 – 0.07   
CONTROL Men 2.20 (0.45) 1.97 (0.51) 0.11–0.34 1.79 (0.47) 1.62 (0.47) 0.05–0.28   
  Women 2.22 (0.48) 2.13 (0.43) −0.05 – 0.22 1.70 (0.54) 1.56 (0.49) −0.01 -0.29   
   Verbal Trait Aggression Physical Trait Aggression   
   Baseline Follow-up CI Baseline Follow-up CI   
ALL Patient 2.01 (0.64) 2.00 (0.55) −0.19 – 0.20 1.71 (0.57) 1.84 (0.60) −0.31 – 0.07   
  Control 2.15 (0.47) 1.96 (0.46) 0.10–0.28 1.93 (0.57) 1.67 (0.54) 0.17–0.35   
ALL Men 2.12 (0.53) 2.02 (0.58) −0.01 – 0.21 1.92 (0.60) 1.81 (0.59) 0.00–0.23   
  Women 2.07 (0.55) 1.88 (0.43) 0.04–0.33 1.73 (0.53) 1.55 (0.46) 0.01–0.33   
PATIENT Men 2.03 (0.62) 2.07 (0.58) −0.26 – 0.18 1.76 (0.59) 1.86 (0.66) −0.33 – 0.13   
  Women 1.95 (0.74) 1.79 (0.38) −0.37 – 0.69 1.54 (0.47) 1.74 (0.39) −0.57 – 0.16   
CONTROL Men 2.18 (0.46) 2.00 (0.48) 0.07–0.31 2.02 (0.58) 1.78 (0.55) 0.14–0.35   
  Women 2.10 (0.50) 1.91 (0.44) 0.04–0.34 1.78 (0.54) 1.50 (0.47) 0.11–0.44   
  1. Data is shown by diagnosis (patient vs control) in all subjects, gender in all subjects, gender among patients and gender among controls